scholarly journals Diagnostic de trouble fonctionnel somatique chez des patients atteints de symptômes neurologiques inexpliqués post-COVID-19 : l’étude SOMATiC (Somatic Symptom Disorder Triggered by COVID-19)

2021 ◽  
Vol 42 ◽  
pp. A329
Author(s):  
A. Kachaner ◽  
L. Cedric ◽  
D. Julie ◽  
D. Salmon ◽  
B. Ranque ◽  
...  
2014 ◽  
Vol 11 (03) ◽  
pp. 149-155
Author(s):  
M. Zaudig

ZusammenfassungDer vorliegende Artikel beschreibt die aktuellen diagnostischen Entwicklungen im Bereich der Somatoformen Störung unter Zugrundelegung der aktuellen S3-Leitlinien für „Nichtspezifische funktionelle und somatoforme Körperbeschwerden“ und der historischen Entwicklung der Somatoformen Störungen (einschließlich der Hypochondrie). Neben einem Vergleich von ICD-10 mit DSM-IV-TR und DSM-5 werden die neuen Kriterien für Somatic Symptom Disorder und Illness Anxiety Disorder (vormals Hypochondrie) nach DSM-5 vorgestellt und diskutiert.


2021 ◽  
pp. 002076402110255
Author(s):  
Chao-Ying Tu ◽  
Wei-Shih Liu ◽  
Yen-Fu Chen ◽  
Wei-Lieh Huang

Background: Somatic symptom disorder (SSD) is common in medical settings but has been underdiagnosed. Stigma related to psychiatric illness was one of the barriers to making the diagnosis. More and more SSD patients who visited psychiatric clinics with physical complaints identify themselves as having ‘autonomic dysregulation’ in Taiwan. Aims: This study aimed to investigate the characteristics of patients with a subjective diagnosis of ‘autonomic dysregulation’. Method: We assessed the sociodemographic profile, medical/psychiatric diagnoses, subjective psychiatric diagnoses, perceived psychiatric stigma, help-seeking attitude, and healthcare utilization of 122 participants with SSD. Participants who identified themselves as having ‘autonomic dysregulation’ ( n = 84) were compared to those who did not (n=38). Results: Participants with a subjective diagnosis of ‘autonomic dysregulation’ were younger and had a higher education level than those who did not have such a subjective diagnosis. They also had higher scores on the Patient Health Questionnaire-15 (PHQ-15) and Health Anxiety Questionnaire (HAQ), whereas comorbid psychiatric diagnoses were similar in the two groups. Participants with and without a subjective diagnosis of ‘autonomic dysregulation’ did not have a significant difference in perceived psychiatric stigma and help-seeking attitude/behaviors. In a multiple logistic regression model, only age was associated with having a subjective diagnosis of ‘autonomic dysregulation’. Conclusion: Among SSD patients, those who identify themselves as having ‘autonomic dysregulation’ tend to have higher somatic distress and health anxiety than those who do not. ‘Autonomic dysregulation’ is not associated with perceived psychiatric stigma.


2021 ◽  
Author(s):  
Deep Bhattacharjee

Psychiatric disorders’ or as emphasized in the paper in the form of somatic-symptom disorder, a sub-category of Schizophrenia has been from the ancient of the human civilization, when the medicinal approach and treatment of the subject hasn’t been developed yet, the notion of the affected subject to be under some spiritual subjugation has automatically been implied on the minds of the people which leads to immense torture and torment of the subject by the society. However, in the modern medical scenario, the situation has shifted from spiritual/evilness to the extreme derision where it has been already implied on the healthy societies brain that, the subject is intentionally acting like a patient or it’s a ‘disease of the mind’ with no associated physical pain which being attributed to the tendency of late diagnosis and recovery, makes the subject a sheer block of ‘sarcasm’ among the healthy society where they tries their best to make ‘the fun out of him’ as regards to his continuous pain and suffering. This generally amplified by the delay in the starting of the treatment for the difficulty of the doctors to diagnose the disease, as not so developed instruments are still in their infancy to detect and derelict the mental disorders, where in most of the time, the golden period of diagnosis is either over or even if psychiatric treatment is initiated can lead to a more defocused effects as doctors itself finds it difficult to approach the right medicine to the disordered person, where, in case, they have to go from one doctor to another in the risk of a trial and error effect.


2021 ◽  
Vol 429 ◽  
pp. 119498
Author(s):  
Stefano Delli Pizzi ◽  
Raffaella Franciotti ◽  
Piero Chiacchiaretta ◽  
Antonio Ferretti ◽  
Astrid Thomas ◽  
...  

Author(s):  
Marco Onofrj ◽  
Mirella Russo ◽  
Claudia Carrarini ◽  
Stefano Delli Pizzi ◽  
Astrid Thomas ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Lukas Berezowski ◽  
Lea Ludwig ◽  
Alexandra Martin ◽  
Bernd Löwe ◽  
Meike C. Shedden-Mora

2016 ◽  
Vol 85 ◽  
pp. 84-85 ◽  
Author(s):  
J. van Eck van der Sluijs ◽  
L. de Vroege ◽  
A. van Manen ◽  
E. van der Thiel ◽  
A. Timmermans ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document